DR. INFO and OpenEvidence, side by side
Available in the Netherlands and Belgium
DR. INFO Yes, on the web and the iPhone app
OpenEvidence No, access ended 28 April 2026
Answers in Dutch
DR. INFO Yes, in the language you ask in; Dutch interface
OpenEvidence No, English only
How it answers
DR. INFO A written answer built from retrieved guidelines and literature, each statement cited
OpenEvidence A written answer with citations, US-oriented sources
Data hosting
DR. INFO European Union, under GDPR
OpenEvidence United States
Guideline sources
DR. INFO European and national guidelines, retrieved per question; the NHG-Standaarden and the Richtlijnendatabase are public and can be asked about
OpenEvidence US-centred
Drug information
DR. INFO FDA and EMA authorised sources, EMA SmPC
OpenEvidence US sources
Documentation
DR. INFO Scribe with SOAP notes and discharge letters in the same product
OpenEvidence None
Regulatory status
DR. INFO CE marked medical device under EU MDR 2017/745
OpenEvidence Not CE marked
HealthBench Hard (same 100 examples)
DR. INFO 0.72
OpenEvidence 0.49
Cost
DR. INFO Free tier, paid plans
OpenEvidence Was free for verified clinicians
| DR. INFO | OpenEvidence | |
|---|---|---|
| Available in the Netherlands and Belgium | Yes, on the web and the iPhone app | No, access ended 28 April 2026 |
| Answers in Dutch | Yes, in the language you ask in; Dutch interface | No, English only |
| How it answers | A written answer built from retrieved guidelines and literature, each statement cited | A written answer with citations, US-oriented sources |
| Data hosting | European Union, under GDPR | United States |
| Guideline sources | European and national guidelines, retrieved per question; the NHG-Standaarden and the Richtlijnendatabase are public and can be asked about | US-centred |
| Drug information | FDA and EMA authorised sources, EMA SmPC | US sources |
| Documentation | Scribe with SOAP notes and discharge letters in the same product | None |
| Regulatory status | CE marked medical device under EU MDR 2017/745 | Not CE marked |
| HealthBench Hard (same 100 examples) | 0.72 | 0.49 |
| Cost | Free tier, paid plans | Was free for verified clinicians |
How DR. INFO compares with OpenEvidence
Rubric graded scores on difficult, open ended clinical conversations, from the same 100 example run. Higher is better.
Source: Ravichandran S, et al. OpenAI’s HealthBench in Action. arXiv:2509.02594.
Frequently asked questions
- Is OpenEvidence available in the Netherlands in 2026?
- No. OpenEvidence terminated app access in the EU and the UK on 28 April 2026, and access from Dutch and other European addresses has been blocked since. The company cited regulatory uncertainty around European AI rules. No return date has been announced.
- Is there a Dutch version of OpenEvidence?
- No. OpenEvidence never answered in Dutch and had no Dutch interface; its sources were US-oriented. DR. INFO answers in the language you ask in, Dutch included, and the product itself is available in Dutch.
- Does the OpenEvidence app still work in the Netherlands or Belgium?
- Not from the Netherlands or Belgium: sign-in and access from European addresses have been blocked since April 2026, in the app and in the browser alike. DR. INFO works in the browser at app.drinfo.ai and on the iPhone app.
- When will OpenEvidence come back?
- There is no date. The withdrawal was tied to European AI regulation, so a return would be a decision by the company rather than a technical fix. A clinician who needs a cited answer to a clinical question today is better off not waiting for it.
- Why did OpenEvidence leave Europe?
- OpenEvidence withdrew from the EU and the UK together, citing uncertainty about European AI regulation, including the EU AI Act. Commentary in the medical press has treated the move as a sign of the regulatory divide between US health AI and European rules [7].
- What do Dutch doctors use instead of OpenEvidence?
- Two kinds of tool. The freely accessible Dutch sources: the NHG-Standaarden for general practice [3], the Richtlijnendatabase of the Federatie Medisch Specialisten [4] and the Farmacotherapeutisch Kompas for medicines [8], all documents to be consulted. And DR. INFO, a European clinical AI that answers a clinical question with citations you can open, hosts data in the EU, and includes a scribe and discharge letter drafting.
- Is DR. INFO the best OpenEvidence alternative for Dutch doctors?
- For a clinician who wanted what OpenEvidence did, a cited written answer to a clinical question, DR. INFO is the closest equivalent that can be used from the Netherlands: it retrieves guidelines and literature for each question, cites every statement, hosts data in the EU, answers in Dutch and scored 0.72 against OpenEvidence's 0.49 on HealthBench Hard.
- How does DR. INFO cite its answers?
- Each answer is written from documents retrieved for that question, and each statement carries a citation that opens the source: a guideline, a peer reviewed paper, or an FDA or EMA drug document. That makes the answer checkable in the way a colleague's summary is not. In a prospective pilot study published in Cureus in 2026, physicians using DR. INFO at the point of care rated that traceability as part of its value [9].
- Can DR. INFO answer questions about the NHG-Standaarden and the Richtlijnendatabase?
- The NHG-Standaarden and the guidelines in the Richtlijnendatabase are public documents, so DR. INFO can be asked about them and cites the source it used in the answer. DR. INFO is not affiliated with the NHG or the Federatie Medisch Specialisten, and the current guideline on their websites remains the version to rely on.
- Where is the data hosted, and what does that mean for a Dutch practice?
- DR. INFO is hosted in the European Union under GDPR, known in the Netherlands as the AVG. Whether a tool may be used with identifiable patient data remains a decision for each practice, hospital and institution, in the Netherlands with its own assessment and a DPIA where needed; the data protection officer is the person to ask.
- Is DR. INFO free for doctors in the Netherlands?
- There is a free tier for doctors and medical students, with paid plans for heavier use. DR. INFO works in the browser at app.drinfo.ai and on the iPhone app, from the Netherlands and Belgium.
- Does DR. INFO also work in Belgium?
- Yes. DR. INFO is available across Europe, Belgium included, and answers in Dutch, in French or in whichever language you ask in. National guidelines follow the country you set; European and international guidelines are returned whatever the country. Our Belgium page covers the Belgian references in detail.
- Is DR. INFO a certified medical device?
- Yes. DR. INFO is CE marked under EU MDR 2017/745 [10] and is developed and operated by Synduct GmbH in Munich.
OpenEvidence is not coming back to the Netherlands on any announced date, there was never a Dutch version, and the NHG-Standaarden and the Richtlijnendatabase were never an answer engine. For a doctor in the Netherlands or Flanders who wants a cited answer to a clinical question, DR. INFO is the tool to try first: built in Europe, hosted in the EU, in Dutch, free to start, and scoring higher than OpenEvidence on the hardest public benchmark of clinical answers.
References
- 1.Breaking: OpenEvidence app access terminated in the UK and EU. Telehealth and Telecare Aware. 28 April 2026.
- 2.The US-based medical search engine OpenEvidence is down in Europe: a commentary on regulatory complexities. Intelligence-Based Medicine. 2026.
- 3.Nederlands Huisartsen Genootschap. NHG-Richtlijnen en NHG-Standaarden.
- 4.Federatie Medisch Specialisten. Richtlijnendatabase.
- 5.Ravichandran S, Kumar S, Corga Da Silva R, Romano M, et al. OpenAI’s HealthBench in Action: Evaluating an LLM-Based Medical Assistant on Realistic Clinical Queries. arXiv:2509.02594. 2026.
- 6.Arora RK, Wei J, Soskin Hicks R, et al. HealthBench: Evaluating Large Language Models Toward Improved Human Health. OpenAI. 2025.
- 7.OpenEvidence exits Europe, highlighting divide in health AI rules. Telehealth.org. 2026.
- 8.Zorginstituut Nederland. Farmacotherapeutisch Kompas.
- 9.Corga Da Silva R, Romano M, Mendes T, et al. DR. INFO at the Point of Care: A Prospective Pilot Study of Physician-Perceived Value of an Agentic Artificial Intelligence Clinical Assistant. Cureus. 2026.
- 10.Regulation (EU) 2017/745 of the European Parliament and of the Council on medical devices (EU MDR). Official Journal of the European Union. 2017.